Acutaas Chemicals Q4 FY26: Revenue up 40%, PAT up 114% YoY

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

ACUTAAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.5%Reaction day

₹2505.00

prior close

₹2523.70

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.4%+3.9% vs market

Pharmaceuticals peers, median of 161sector-0.3%+3.8% vs sector

On the reaction day the stock moved 3.9 pts more than Nifty Smallcap 250 and 3.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.1

15m

-0.1

30m

+6.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.5-0.4+3.9-0.3+3.8

Next day

+7.2+0.5+6.6+0.3+6.9

+6.6+0.7+5.9+0.5+6.1

+7.1+2.6+4.5+1.8+5.3

+9.2+3.6+5.6+3.1+6.0

+9.6+3.8+5.8+3.6+6.0

+10.2-0.4+10.6+1.6+8.6

15d

+17.9-0.2+18.1+1.7+16.2

+20.3+0.3+20.0+2.5+17.8

+41.2+5.5+35.7+5.7+35.5

+29.0+6.2+22.8+7.8+21.3

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 161Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Acutaas Chemicals reported strong Q4 & FY26 results. Q4 FY26 revenue grew 40.3% YoY to ₹4,328mn, PAT up 114.1% to ₹1,343mn (margin 31.0%). EBITDA margin surged to 42.4% from 27.5%. FY26 revenue rose 33% to ₹13,394mn; PAT jumped 122% to ₹3,564mn; EBITDA margin expanded to 35.9% from 23.0%. Management guided 25% revenue growth in FY27, citing battery chemicals, semiconductors, and pharma CDMO verticals.

Likely market impact

Strong beat across revenue, margins, and PAT signals robust growth and pricing power; positive outlook supports bullish sentiment.